Sitagliptin is an oral antihyperglycemic (antidiabetic drug) of the dipeptidyl
peptidase-4 (DPP-4) inhibitor class. It was developed, and is marketed, by Merck
Easy to read patient leaflet for sitagliptin. Includes indications, proper use, special
instructions, precautions, and possible side effects.
Sitagliptin is a new oral hypoglycemic (anti-diabetic drug) of the new dipeptidyl
peptidase-4 (DPP-4) inhibitor class of drugs. This enzyme-inhibiting drug is to be
Find patient medical information for sitagliptin oral on WebMD including its uses,
side effects and safety, interactions, pictures, warnings and user ratings.
Learn about Januvia (Sitagliptin Phosphate) may treat, uses, dosage, side effects
, drug interactions, warnings, patient labeling, reviews, and related ...
Sitagliptin is an antidiabetic used to treat diabetes. Read about sitagliptin and it's
side effects and dosage information online at Patient.
Learn about clinical pharmacology for the drug Januvia (Sitagliptin Phosphate).
Mar 14, 2016 ... However, because sitagliptin is primarily renally eliminated, severe hepatic
impairment is not expected to affect the pharmacokinetics of ...
Jul 15, 2015 ... Sitagliptin, the first in a new class of diabetic drugs called dipeptidyl peptidase-4 (
DPP-4) inhibitors, is approved as an adjunct to diet and ...
JANUMET is a powerful type 2 diabetes medicine that combines 2 prescription
medicines, sitagliptin (JANUVIA<sup>®</sup>) and metformin, and can lower blood sugar ...